Abstrakt

Przypisy

• 1. Abe S., Kurata M., Suzuki S., Yamamoto K., Aisaki K., Kanno J.,Kitagawa M.: Minichromosome maintenance 2 bound with retroviralgp70 is localized to cytoplasm and enhances DNA-damage-inducedapoptosis. PLoS One, 2012; 7: e40129
  Google Scholar
• 1. Abe S., Kurata M., Suzuki S., Yamamoto K., Aisaki K., Kanno J.,Kitagawa M.: Minichromosome maintenance 2 bound with retroviralgp70 is localized to cytoplasm and enhances DNA-damage-inducedapoptosis. PLoS One, 2012; 7: e40129
  Google Scholar
• 2. Amaro Filho S.M., Nuovo G.J., Cunha C.B., Ramos Pereira L. de O.,Oliveira-Silva M., Russomano F., Pires A., Nicol A.F.: Correlation ofMCM2 detection with stage and virology of cervical cancer. Int. J.Biol. Markers, 2014; 29: 363 – 371
  Google Scholar
• 2. Amaro Filho S.M., Nuovo G.J., Cunha C.B., Ramos Pereira L. de O.,Oliveira-Silva M., Russomano F., Pires A., Nicol A.F.: Correlation ofMCM2 detection with stage and virology of cervical cancer. Int. J.Biol. Markers, 2014; 29: 363 – 371
  Google Scholar
• 3. Ananthanarayanan V., Deaton R.J., Yang X.J., Pins M.R., GannP.H.: Alteration of proliferation and apoptotic markers in normaland premalignant tissue associated with prostate cancer. BMC Cancer,2006; 6: 73
  Google Scholar
• 3. Ananthanarayanan V., Deaton R.J., Yang X.J., Pins M.R., GannP.H.: Alteration of proliferation and apoptotic markers in normaland premalignant tissue associated with prostate cancer. BMC Cancer,2006; 6: 73
  Google Scholar
• 4. Bochman M.L., Schwacha A.: The Mcm complex: unwinding themechanism of a replicative helicase. Microbiol. Mol. Biol. Rev., 2009;73: 652-683
  Google Scholar
• 4. Bochman M.L., Schwacha A.: The Mcm complex: unwinding themechanism of a replicative helicase. Microbiol. Mol. Biol. Rev., 2009;73: 652-683
  Google Scholar
• 5. Bukholm I.R., Bukholm G., Holm R., Nesland J.M.: Associationbetween histology grade, expression of HsMCM2, and cyclin A inhuman invasive breast carcinomas. J. Clin. Pathol., 2003; 56: 368-373
  Google Scholar
• 5. Bukholm I.R., Bukholm G., Holm R., Nesland J.M.: Associationbetween histology grade, expression of HsMCM2, and cyclin A inhuman invasive breast carcinomas. J. Clin. Pathol., 2003; 56: 368-373
  Google Scholar
• 6. Cho Mar K., Eimoto T., Nagaya S., Tateyama H.: Cell proliferationmarker MCM2, but not Ki67, is helpful for distinguishing betweenminimally invasive follicular carcinoma and follicular adenoma ofthe thyroid. Histopathology, 2006; 48: 801-807 7 Chuang C.H., Yang D., Bai G., Freeland A., Pruitt S.C., SchimentiJ.C.: Post-transcriptional homeostasis and regulation of MCM2-7 inmammalian cells. Nucleic Acids Res., 2012; 40: 4914-4924
  Google Scholar
• 6. Cho Mar K., Eimoto T., Nagaya S., Tateyama H.: Cell proliferationmarker MCM2, but not Ki67, is helpful for distinguishing betweenminimally invasive follicular carcinoma and follicular adenoma ofthe thyroid. Histopathology, 2006; 48: 801-807 7 Chuang C.H., Yang D., Bai G., Freeland A., Pruitt S.C., SchimentiJ.C.: Post-transcriptional homeostasis and regulation of MCM2-7 inmammalian cells. Nucleic Acids Res., 2012; 40: 4914-4924
  Google Scholar
• 7. ATPase motifs during replication initiation. Mol. Cell, 2014; 55:655-665
  Google Scholar
• 7. ATPase motifs during replication initiation. Mol. Cell, 2014; 55:655-665
  Google Scholar
• 8. Cohn S.L., Pearson A.D., London W.B., Monclair T., Ambros P.F.,Brodeur G.M., Faldum A., Hero B., Iehara T., Machin D., Mosseri V.,Simon T., Garaventa A., Castel V., Matthay K.K.: The InternationalNeuroblastoma Risk Group (INRG) classification system: an INRGtask force report. J. Clin. Oncol., 2009; 27: 289-297
  Google Scholar
• 8. Cohn S.L., Pearson A.D., London W.B., Monclair T., Ambros P.F.,Brodeur G.M., Faldum A., Hero B., Iehara T., Machin D., Mosseri V.,Simon T., Garaventa A., Castel V., Matthay K.K.: The InternationalNeuroblastoma Risk Group (INRG) classification system: an INRGtask force report. J. Clin. Oncol., 2009; 27: 289-297
  Google Scholar
• 9. Czyżewska J., Guzińska-Ustymowicz K., Pryczynicz A., Kemona A.,Bandurski R.: Immunohistochemical evaluation of Ki-67, PCNA andMCM2 proteins proliferation index (PI) in advanced gastric cancer.Folia Histochem. Cytobiol., 2009; 47: 289-296
  Google Scholar
• 9. Czyżewska J., Guzińska-Ustymowicz K., Pryczynicz A., Kemona A.,Bandurski R.: Immunohistochemical evaluation of Ki-67, PCNA andMCM2 proteins proliferation index (PI) in advanced gastric cancer.Folia Histochem. Cytobiol., 2009; 47: 289-296
  Google Scholar
• 10. Drui A.E., Tsaur G.A., Shorikov E.V., Popov A.M., Plekhanova O.M.,Typonogov S.N., Savel’ev L.I., Tsvirenko S.V., Fechina L.G.: Methodsof detection and prognostic significance of genetic material increaseof the short arm of chromosome 2 and a deletion of the short armof chromosome 1 in patients with neuroblastoma. Vopr. Onkol.,2013; 59: 591-598
  Google Scholar
• 10. Drui A.E., Tsaur G.A., Shorikov E.V., Popov A.M., Plekhanova O.M.,Typonogov S.N., Savel’ev L.I., Tsvirenko S.V., Fechina L.G.: Methodsof detection and prognostic significance of genetic material increaseof the short arm of chromosome 2 and a deletion of the short armof chromosome 1 in patients with neuroblastoma. Vopr. Onkol.,2013; 59: 591-598
  Google Scholar
• 11. Endl E., Gerdes J.: The Ki-67 protein: fascinating forms and anunknown function. Exp. Cell Res., 2000; 257: 231-237
  Google Scholar
• 11. Endl E., Gerdes J.: The Ki-67 protein: fascinating forms and anunknown function. Exp. Cell Res., 2000; 257: 231-237
  Google Scholar
• 12. Endl E., Gerdes J.: Posttranslational modifications of the Ki-67protein coincide with two major checkpoints during mitosis. J. Cell.Physiol., 2000; 182: 371-380
  Google Scholar
• 12. Endl E., Gerdes J.: Posttranslational modifications of the Ki-67protein coincide with two major checkpoints during mitosis. J. Cell.Physiol., 2000; 182: 371-380
  Google Scholar
• 13. Evrin C., Fernandez-Cid A., Riera A., Lech J., Clarke P., HerreraM.C., Tognetti S., Lurz R., Speck C.: The ORC/Cdc6/MCM2-7 complexfacilitates MCM2-7 dimerization during prereplicative complex formation.Nucleic Acids Res., 2014; 42: 2257-2269
  Google Scholar
• 13. Evrin C., Fernandez-Cid A., Riera A., Lech J., Clarke P., HerreraM.C., Tognetti S., Lurz R., Speck C.: The ORC/Cdc6/MCM2-7 complexfacilitates MCM2-7 dimerization during prereplicative complex formation.Nucleic Acids Res., 2014; 42: 2257-2269
  Google Scholar
• 14. Gakiopoulou H., Korkolopoulou P., Levidou G., Thymara I., SaettaA., Piperi C., Givalos N., Vassilopoulos I., Ventouri K., Tsenga A.,Bamias A., Dimopoulos M.A., Agapitos E., Patsouris E.: Minichromosomemaintenance proteins 2 and 5 in non-benign epithelial ovariantumours: relationship with cell cycle regulators and prognosticimplications. Br. J. Cancer, 2007; 97: 1124-1134
  Google Scholar
• 14. Gakiopoulou H., Korkolopoulou P., Levidou G., Thymara I., SaettaA., Piperi C., Givalos N., Vassilopoulos I., Ventouri K., Tsenga A.,Bamias A., Dimopoulos M.A., Agapitos E., Patsouris E.: Minichromosomemaintenance proteins 2 and 5 in non-benign epithelial ovariantumours: relationship with cell cycle regulators and prognosticimplications. Br. J. Cancer, 2007; 97: 1124-1134
  Google Scholar
• 15. Giaginis C., Georgiadou M., Dimakopoulou K., Tsourouflis G., GatzidouE., Kouraklis G., Theocharis S.: Clinical significance of MCM-2and MCM-5 expression in colon cancer: association with clinicopathologicalparameters and tumor proliferative capacity. Dig. Dis.Sci., 2009; 54: 282-291
  Google Scholar
• 15. Giaginis C., Georgiadou M., Dimakopoulou K., Tsourouflis G., GatzidouE., Kouraklis G., Theocharis S.: Clinical significance of MCM-2and MCM-5 expression in colon cancer: association with clinicopathologicalparameters and tumor proliferative capacity. Dig. Dis.Sci., 2009; 54: 282-291
  Google Scholar
• 16. Giaginis C., Vgenopoulou S., Vielh P., Theocharis S.: MCM proteinsas diagnostic and prognostic tumor markers in the clinicalsetting. Histol. Histopathol., 2010; 25; 351-370
  Google Scholar
• 16. Giaginis C., Vgenopoulou S., Vielh P., Theocharis S.: MCM proteinsas diagnostic and prognostic tumor markers in the clinicalsetting. Histol. Histopathol., 2010; 25; 351-370
  Google Scholar
• 17. Hashimoto K., Araki K., Osaki M., Nakamura H., Tomita K., ShimizuE., Ito H.: MCM2 and Ki-67 expresion in human lung adenocarcinoma:prognostic implications. Pathobiology, 2004; 71: 193-200
  Google Scholar
• 17. Hashimoto K., Araki K., Osaki M., Nakamura H., Tomita K., ShimizuE., Ito H.: MCM2 and Ki-67 expresion in human lung adenocarcinoma:prognostic implications. Pathobiology, 2004; 71: 193-200
  Google Scholar
• 18. Hua C., Zhao G., Li Y., Bie L.: Minichromosome maintenance(MCM) family as potencial diagnostic and prognostic tumor markersfor human gliomas. BMC Cancer, 2014; 14: 526
  Google Scholar
• 18. Hua C., Zhao G., Li Y., Bie L.: Minichromosome maintenance(MCM) family as potencial diagnostic and prognostic tumor markersfor human gliomas. BMC Cancer, 2014; 14: 526
  Google Scholar
• 19. Ibarra A., Schwob E., Méndez J.: Excess MCM proteins protecthuman cells from replicative stress by licensing backup origins ofreplication. Proc. Natl. Acad. Sci. USA, 2008; 105: 8956-8961
  Google Scholar
• 19. Ibarra A., Schwob E., Méndez J.: Excess MCM proteins protecthuman cells from replicative stress by licensing backup origins ofreplication. Proc. Natl. Acad. Sci. USA, 2008; 105: 8956-8961
  Google Scholar
• 20. Ishimi Y., Sugiyama T., Nakaya R., Kanamori M., Kohno T., EnomotoT., Chino H.: Effect of heliquinomycin on the activity of humanminichromosome maintenance 4/6/7 helicase. FEBS J., 2009;276: 3382-3391
  Google Scholar
• 20. Ishimi Y., Sugiyama T., Nakaya R., Kanamori M., Kohno T., EnomotoT., Chino H.: Effect of heliquinomycin on the activity of humanminichromosome maintenance 4/6/7 helicase. FEBS J., 2009;276: 3382-3391
  Google Scholar
• 21. Kamijo T., Nakagawara A.: Molecular and genetic bases of neuroblastoma.Int. J. Clin. Oncol., 2012; 17: 190-195
  Google Scholar
• 21. Kamijo T., Nakagawara A.: Molecular and genetic bases of neuroblastoma.Int. J. Clin. Oncol., 2012; 17: 190-195
  Google Scholar
• 22. Kang S., Warner M.D., Bell S.P.: Multiple functions for Mcm2-
  Google Scholar
• 22. Kang S., Warner M.D., Bell S.P.: Multiple functions for Mcm2-
  Google Scholar
• 23. Kato H., Miyazaki T., Fukai Y., Nakajima M., Sohda M., Takita J.,Masuda N., Fukuchi M., Manda R., Ojima H., Tsukada K., Asao T., KuwanoH.: A new proliferation marker, minichromosome maintenanceprotein 2, is associated with tumor aggressiveness in esophagealsquamous cell carcinoma. J. Surg. Oncol., 2003; 84: 24-30
  Google Scholar
• 23. Kato H., Miyazaki T., Fukai Y., Nakajima M., Sohda M., Takita J.,Masuda N., Fukuchi M., Manda R., Ojima H., Tsukada K., Asao T., KuwanoH.: A new proliferation marker, minichromosome maintenanceprotein 2, is associated with tumor aggressiveness in esophagealsquamous cell carcinoma. J. Surg. Oncol., 2003; 84: 24-30
  Google Scholar
• 24. Kiyonari S., Kadomatsu K.: Neuroblastoma models for insightsinto tumorgenesis and new therapies. Expert Opin. Drug Discov.,2015; 10: 53-62
  Google Scholar
• 24. Kiyonari S., Kadomatsu K.: Neuroblastoma models for insightsinto tumorgenesis and new therapies. Expert Opin. Drug Discov.,2015; 10: 53-62
  Google Scholar
• 25. Koppen A., Ait-Aissa R., Koster J., van Sluis P.G., Ora I., CaronH.N., Volckmann R., Versteeg R., Valentijn L.J.: Direct regulation ofthe minichromosome maintenance complex by MYCN in neuroblastoma.Eur. J. Cancer, 2007; 43: 2413-2422
  Google Scholar
• 25. Koppen A., Ait-Aissa R., Koster J., van Sluis P.G., Ora I., CaronH.N., Volckmann R., Versteeg R., Valentijn L.J.: Direct regulation ofthe minichromosome maintenance complex by MYCN in neuroblastoma.Eur. J. Cancer, 2007; 43: 2413-2422
  Google Scholar
• 26. Kundu L.R., Kumata Y., Kakusho N., Watanabe S., Furukohri A.,Waga S., Seki M., Masai H., Enomoto T., Tada S.: Deregulated Cdc6inhibits DNA replication and suppresses Cdc7-mediated phosphorylationof Mcm2-7 complex. Nucleic Acids Res., 2010; 38: 5409-5418
  Google Scholar
• 26. Kundu L.R., Kumata Y., Kakusho N., Watanabe S., Furukohri A.,Waga S., Seki M., Masai H., Enomoto T., Tada S.: Deregulated Cdc6inhibits DNA replication and suppresses Cdc7-mediated phosphorylationof Mcm2-7 complex. Nucleic Acids Res., 2010; 38: 5409-5418
  Google Scholar
• 27. Louis C.U., Shohet J.M.: Neuroblastoma: molecular pathogenesisand therapy. Annu. Rev. Med., 2015; 66: 49-63
  Google Scholar
• 27. Louis C.U., Shohet J.M.: Neuroblastoma: molecular pathogenesisand therapy. Annu. Rev. Med., 2015; 66: 49-63
  Google Scholar
• 28. Masata M., Juda P., Raska O., Cardoso M.C., Raska I.: A fractionof MCM 2 proteins remain associated with replication foci during amajor part of S phase. Folia Biol., 2011; 57: 3-11
  Google Scholar
• 28. Masata M., Juda P., Raska O., Cardoso M.C., Raska I.: A fractionof MCM 2 proteins remain associated with replication foci during amajor part of S phase. Folia Biol., 2011; 57: 3-11
  Google Scholar
• 29. Modak S., Cheung N.K.: Neuroblastoma: therapeutic strategiesfor a clinical enigma. Cancer Treat. Rev., 2010; 36: 307-317
  Google Scholar
• 29. Modak S., Cheung N.K.: Neuroblastoma: therapeutic strategiesfor a clinical enigma. Cancer Treat. Rev., 2010; 36: 307-317
  Google Scholar
• 30. Nowińska K., Dzięgiel P.: Białka MCM i ich rola w proliferacjikomórek i procesie nowotworowym. Postępy Hig. Med. Dośw., 2010;64: 627-635
  Google Scholar
• 30. Nowińska K., Dzięgiel P.: Białka MCM i ich rola w proliferacjikomórek i procesie nowotworowym. Postępy Hig. Med. Dośw., 2010;64: 627-635
  Google Scholar
• 31. Ohali A., Avigad S., Ash S., Goshen Y., Luria D., Feinmesser M.,Zaizov R., Yaniv I.: Telomere length is a prognostic factor in neuroblastoma.Cancer, 2006; 107: 1391-1399
  Google Scholar
• 31. Ohali A., Avigad S., Ash S., Goshen Y., Luria D., Feinmesser M.,Zaizov R., Yaniv I.: Telomere length is a prognostic factor in neuroblastoma.Cancer, 2006; 107: 1391-1399
  Google Scholar
• 32. Parodi F., Passoni L., Massimo L., Luksch R., Gambini C., Rossi E.,Zuffardi O., Pistoia V., Pezzolo A.: Identification of novel prognosticmarkers in relapsing localized resectable neuroblastoma. OMICS,2011; 15: 113-121
  Google Scholar
• 32. Parodi F., Passoni L., Massimo L., Luksch R., Gambini C., Rossi E.,Zuffardi O., Pistoia V., Pezzolo A.: Identification of novel prognosticmarkers in relapsing localized resectable neuroblastoma. OMICS,2011; 15: 113-121
  Google Scholar
• 33. Passoni L., Longo L., Collini P., Coluccia A.M., Bozzi F., Podda M.,Gregorio A., Gambini C., Garaventa A., Pistoia V., Del Grosso F., ToniniG.P., Cheng M., Gambacorti-Passerini C., Anichini A., et al.: Mutationindependentanaplastic lymphoma kinase overexpression in poor prognosis neuroblastoma patients. Cancer Res., 2009; 69: 7338-7346
  Google Scholar
• 33. Passoni L., Longo L., Collini P., Coluccia A.M., Bozzi F., Podda M.,Gregorio A., Gambini C., Garaventa A., Pistoia V., Del Grosso F., ToniniG.P., Cheng M., Gambacorti-Passerini C., Anichini A., et al.: Mutationindependentanaplastic lymphoma kinase overexpression in poor prognosis neuroblastoma patients. Cancer Res., 2009; 69: 7338-7346
  Google Scholar
• 34. Riera A., Fernandez-Cid A., Speck C.: The ORC/Cdc6/MCM2-7complex, a new power player for regulated helicase loading. CellCycle, 2013; 12: 2155-2156
  Google Scholar
• 34. Riera A., Fernandez-Cid A., Speck C.: The ORC/Cdc6/MCM2-7complex, a new power player for regulated helicase loading. CellCycle, 2013; 12: 2155-2156
  Google Scholar
• 35. Riera A., Li H., Speck C.: Seeing is believing: the MCM 2-7 complexhelicase trapped in complex with its DNA loader. Cell Cycle,2013; 12; 2917-2918
  Google Scholar
• 35. Riera A., Li H., Speck C.: Seeing is believing: the MCM 2-7 complexhelicase trapped in complex with its DNA loader. Cell Cycle,2013; 12; 2917-2918
  Google Scholar
• 36. Rodins K., Cheale M., Coleman N., Fox S.B.: Minichromosomemaintenance protein 2 expression in normal kidney and renal cellcarcinomas: relationship to tumor dormancy and potential clinicalutility. Clin. Cancer Res., 2002; 8: 1075-1081
  Google Scholar
• 36. Rodins K., Cheale M., Coleman N., Fox S.B.: Minichromosomemaintenance protein 2 expression in normal kidney and renal cellcarcinomas: relationship to tumor dormancy and potential clinicalutility. Clin. Cancer Res., 2002; 8: 1075-1081
  Google Scholar
• 37. Scholzen T., Gerdes J.: The Ki-67 protein: from the known andthe unknown. J. Cell. Physiol., 2000; 182: 311-322
  Google Scholar
• 37. Scholzen T., Gerdes J.: The Ki-67 protein: from the known andthe unknown. J. Cell. Physiol., 2000; 182: 311-322
  Google Scholar
• 38. Simon N., Bochman M.L., Seguin S., Brodsky J.L., Seibel W.L.,Schwacha A.: Ciprofloxacin is an inhibitor of the MCM2-7 replicativehelicase. Biosci. Rep., 2013; 33: 783-795
  Google Scholar
• 38. Simon N., Bochman M.L., Seguin S., Brodsky J.L., Seibel W.L.,Schwacha A.: Ciprofloxacin is an inhibitor of the MCM2-7 replicativehelicase. Biosci. Rep., 2013; 33: 783-795
  Google Scholar
• 39. Sington J.D., Freeman A., Morris L.S., Vowler S.L., Arch B.N.,Fisher C., Coleman N.: Minichromosome maintenance protein inmyxofibrosarcoma. Mod. Pathol., 2004; 17: 235-240
  Google Scholar
• 39. Sington J.D., Freeman A., Morris L.S., Vowler S.L., Arch B.N.,Fisher C., Coleman N.: Minichromosome maintenance protein inmyxofibrosarcoma. Mod. Pathol., 2004; 17: 235-240
  Google Scholar
• 40. Szelachowska J., Dziegiel P., Jelen-Krzeszewska J., Jelen M., MatkowskiR., Pomiecko A., Spytkowska B., Jagas M., Gisterek I., KornafelJ.: Mcm-2 protein expression predicts prognosis better than Ki-67antigen in oral cavity squamocellular carcinoma. Anticancer Res.,2006; 26: 2473-2478
  Google Scholar
• 40. Szelachowska J., Dziegiel P., Jelen-Krzeszewska J., Jelen M., MatkowskiR., Pomiecko A., Spytkowska B., Jagas M., Gisterek I., KornafelJ.: Mcm-2 protein expression predicts prognosis better than Ki-67antigen in oral cavity squamocellular carcinoma. Anticancer Res.,2006; 26: 2473-2478
  Google Scholar
• 41. Tan D.F., Huberman J.A., Hyland A., Loewen G.M., Brooks J.S.,Beck A.F., Todorov I.T., Bepler G.: MCM2-a promising marker for premalignantlesions of the lung: a cohort study. BMC Cancer, 2001; 1: 6
  Google Scholar
• 41. Tan D.F., Huberman J.A., Hyland A., Loewen G.M., Brooks J.S.,Beck A.F., Todorov I.T., Bepler G.: MCM2-a promising marker for premalignantlesions of the lung: a cohort study. BMC Cancer, 2001; 1: 6
  Google Scholar
• 42. You Z., De Falco M., Kamada K., Pisani F.M., Masai H.: The Minichromosomemaintenance (Mcm) complexes interact with DNApolymerase α-primase and stimulate its ability to synthesize RNAprimers. PLoS One, 2013; 8: e72408
  Google Scholar
• 42. You Z., De Falco M., Kamada K., Pisani F.M., Masai H.: The Minichromosomemaintenance (Mcm) complexes interact with DNApolymerase α-primase and stimulate its ability to synthesize RNAprimers. PLoS One, 2013; 8: e72408
  Google Scholar

Pełna treść artykułu